Yale Bulletin and Calendar

May 2, 2008|Volume 36, Number 28|Two-Week Issue


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Researchers trace chlorine’s irritative
effect to a specific nerve receptor

Inhaling chlorine triggers a nerve receptor that protects healthy people by inducing sneezing, coughing and irritation, but can cause major problems for people with asthma and other respiratory problems, Yale School of Medicine researchers report in the April 8 Journal of Clinical Investigation.

Prior to this study it was thought that chlorine and other oxidants induced pain and inflammation only through tissue injury. But the Yale team observed that mice lacking the receptor TRPA1 were insensitive to exposure to chlorine — which is used in industrial synthesis, for disinfection of drinking water and swimming pools and in household bleach. Interestingly, say the researchers, the receptor is the same one triggered by pungent mustard and noxious chemicals in cigarette smoke.

“We show that chlorine activates a specific receptor, TRPA1, in pain-sensing nerve endings in the airways,” says corresponding author, Sven-Eric Jordt, assistant professor of pharmacology. “We identified a population of neurons that fire in response to chlorine exposure, inducing pain and irritation, and narrowing airway passages — probably to protect the lung from chlorine damage.”

The problem with this response, he says, is that people whose respiratory systems already are compromised by asthma or congestion from colds and allergies then have a hypersensitive response to chemicals — their lungs are already doing what the brain is telling the respiratory system to do to protect itself.

“In these patients chlorine and other TRPA1 activators can trigger constriction of the bronchial pathways, and cause pain and discomfort in the airways,” Jordt says.

The silver lining, notes Jordt, is that the study points to TRPA1 as a promising new target for the development of new drugs to suppress coughs and relieve pain and inflammation.

The lead authors are Bret Bessac and Michael Sivula of Yale. The study was conducted in collaboration with the laboratory of Lauren Cohn in the pulmonary section of Internal Medicine at Yale and funded by grants from the National Institute of Environmental Health Sciences of the National Institutes of Health.

By Jacqueline Weaver


T H I SW E E K ' SS T O R I E S

Findings may explain how cancer spreads

Students learning to blend economic savvy and environmental . . .

Outreach programs showing city students science is . . .

Students demonstrate energy-harvesting designs

A Beautiful Day in the Neighborhood

Alumnus Stephen Pitti named new master of Ezra Stiles College

Former Norwalk mayor Alex Knopp chosen to head Dwight Hall

Study identifies factors that predict premature babies’ survivability . . .

Center celebrates decade of shaping graduate student life

Library acquires alumnus’ images of a changing Iowa

Staff member’s Mt. McKinley climb will support cancer research

Carlotta Festival showcases work of graduating playwrights

Celebrated writers will discuss their craft in Yale Library talk

Researchers trace chlorine’s irritative effect to a specific nerve receptor

Student Research Day to feature prize-winning presentations . . .

Inaugural James Weldon Johnson Fellow to research . . .

Researcher Kenneth Pugh, a reading specialist, is appointed . . .

Conference to explore psychosocial and physical dimensions of . . .

Memorial service for Dr. Steven C. Hebert

Yale Books in Brief

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home